Cabio Biotech (Wuhan) Co., Ltd.

Cabio Biotech (Wuhan) Co., Ltd.


Company description

CABIO Bioengineering (Wuhan) Co Ltd (CABIO), is a hi-tech venture jointly founded by Wuhan Alking Bioengineering Co Ltd.and Cargill Incorporated. It has two wholly-owned subsidiaries in Gedian and Jiangxia respectively.

CABIO is the first company in China to engage in the production of unsaturated fatty acid with fermentation technology;which mainly serves ARA and Docosahexaenoic acid derived from microalga(DHA algal oil) and other high-end food ingredients; is the leading brand in the ARA industry in China; is the only Chinese company whose ARA products have been approved as the NOVEL FOOD by European Commission and as GRAS by the U.S. FDA. We have taken the leading role in drafting state standards for food safety regarding ARA and DHA (with the fermentation method); and have two advanced plants manufacturing ARA and DHA monomers currently.

Quick facts

Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central America; Central/South America; East Asia (e.g., China, Japan, Korea); South America; South Asia (e.g. India, Pakistan, Sri Lanka, e.t.c); South East Asia (e.g., Tailand, Philippines, Singapore, e.t.c.)
Affiliated categories: Fat Replacers |Flavour Enhancers |Nutrients More

Upcoming events

7 sep 2022

Fi Asia - Indonesia 2022

7 - 9 September 2022 Jakarta, Indonesia Visit us at stand A-P35 Book a meeting See our Exhibitor Profile   See full Exhibitor List

Recently at

23 jun 2021

Hi & Fi Asia-China 2021

23 - 25 June 2021 Shanghai, China We were at stand 41D40 See our Exhibitor Profile   See full Exhibitor List

Categories affiliated with Cabio Biotech (Wuhan) Co., Ltd.

Cabio Biotech (Wuhan) Co., Ltd.

Contact information




View all contact information